Skip to content

Clinical trials

Understanding clinical trials and how to look for appropriate studies.

Clinical trials evaluate new approaches to cancer prevention, diagnosis, treatment and supportive care. Whether a particular study may be relevant depends on its eligibility criteria, the patient's diagnosis, stage, previous treatment, molecular findings, overall health and study location.

Institute status

Current Institute Trial Status

Dr AV Institute is not currently enrolling participants into an active clinical trial.

The resources on this page are provided to help patients and clinicians understand clinical trials and explore registered research opportunities.

Trusted sources

Search trusted clinical-trial registries.

This website does not list open studies, confirm eligibility, hold places or arrange enrolment. Use these authoritative registries to search for currently registered studies.
  • Clinical Trials Registry — India (CTRI)

    India's national clinical-trial registry. Search registered studies by condition, phase, recruitment status and location.

    Search CTRI
  • ClinicalTrials.gov

    A large international registry of publicly and privately supported clinical studies.

    Search ClinicalTrials.gov
  • National Cancer Institute — Cancer Clinical Trials

    Cancer-specific trial search and educational guidance from the US National Cancer Institute.

    Search NCI Cancer Trials
  • WHO International Clinical Trials Registry Platform

    A WHO search portal that brings together trial-registration records supplied by participating registries around the world.

    Search WHO ICTRP

Learn more

Understanding clinical trials.

  • What is a clinical trial?

    A clinical trial is a research study conducted with human participants to answer a specific scientific question, most often to evaluate whether a new drug, device, combination or approach is safe and effective. Trials follow a written protocol and are reviewed by an ethics committee before any participant is enrolled.

  • The different phases

    Phase 1 studies mainly assess safety and dosing in a small number of participants. Phase 2 studies look further at safety and early signs of effect. Phase 3 studies compare a new approach against standard treatment in larger groups. Phase 4 studies follow an approved treatment after it is already in routine use.

  • Why eligibility criteria matter

    Every trial defines inclusion and exclusion criteria — such as diagnosis, stage, prior treatment, organ function and specific biomarkers — designed to protect participant safety and produce a meaningful scientific answer. Meeting some criteria does not guarantee meeting all of them, and only the study team can confirm eligibility after formal review.

  • Standard treatment versus investigational treatment

    Standard treatment has established evidence of safety and effectiveness for a given diagnosis and is the usual recommended approach. Investigational treatment is being studied because its benefit, safety profile or place in care is not yet established. Choosing to pursue a trial is a decision to be made with the treating oncologist, alongside standard options.

  • Informed consent and voluntary participation

    Before joining any trial, participants are given detailed written information and time to ask questions, and must provide informed consent. Participation in a clinical trial is voluntary, and a person may decline or withdraw at any stage without it affecting their standard care.

  • Questions to discuss with your oncologist

    Is a clinical trial relevant to my diagnosis and stage? What standard options exist, and how would a trial compare? What would participation involve in terms of visits, tests and travel? What are the known and unknown risks? Who do I contact if I have concerns during the study?

Information that helps when searching for a trial

The following is guidance only, to help you and your oncologist prepare for a registry search. None of this information is collected on this website.

  • Exact cancer diagnosis/subtype
  • Stage
  • Pathology
  • Relevant biomarkers/molecular findings
  • Previous treatments
  • Current treatment
  • Age
  • General health/performance status
  • Location/travel feasibility

Important to know

Finding a study in a registry does not mean that the study is currently available to you or that you are eligible to participate. Recruitment status and study details may change. Trial suitability should be reviewed with the treating oncology team and confirmed by the study investigators.

Voluntary participation

Participation in a clinical trial is voluntary. Do not stop or change established treatment in order to pursue a trial without discussing this with your treating oncologist.

This website does not list open studies, confirm eligibility, hold places or arrange enrolment, and it does not state that any treatment is available through a study. Study listings and availability change continuously and are confirmed only by the team running the study.

Discuss whether a clinical trial or standard treatment is the right next step.

Suitability depends on diagnosis, prior treatment, current condition and molecular findings, and is assessed in consultation.

CallRequest a ConsultationSecond Opinion